COST-EFFECTIVENESS ANALYSIS OF INFLIXIMAB VERSUS CYCLOSPORINE IN STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS

被引：0
|
作者：
Luong, J. [1 ]
机构：
[1] Univ Washington, Seattle, WA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE152
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [41] Predictors of Avoidance of Colectomy with Infliximab Initiation in Severe, IV Steroid-Refractory Ulcerative Colitis
    Zisman, Timothy L.
    Lewis, Jeffrey R.
    Stein, Adam C.
    Mayorga, Christian A.
    Cohen, Russell D.
    GASTROENTEROLOGY, 2009, 136 (05) : A660 - A660
  • [42] COST-EFFECTIVENESS OF INFLIXIMAB VERSUS COLECTOMY FOR THE TREATMENT OF SEVERE ACTIVE ULCERATIVE COLITIS IN POLAND
    Ska, Goszczy K.
    Wrona, W.
    Niewada, M.
    Black, C. M.
    Fan, T.
    Lobodzinski, P.
    VALUE IN HEALTH, 2013, 16 (03) : A213 - A214
  • [43] COST-EFFECTIVENESS OF GOLIMUMAB VERSUS INFLIXIMAB AND ADALIMUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS
    Thorlund, K.
    Druyts, E.
    Eapen, S.
    Mills, E.
    VALUE IN HEALTH, 2014, 17 (03) : A38 - A38
  • [44] Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis
    Druyts, Kristian Thorlund Eric
    Kanters, Steve
    Eapen, Shawn
    Mills, Edward
    GASTROENTEROLOGY, 2014, 146 (05) : S202 - S202
  • [45] Cyclosporine Rescue in Vedolizumab Patients with Steroid-Refractory Severe Ulcerative Colitis: A Case Series
    Pineles, David
    Chang, Shannon
    Hudesman, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S841 - S842
  • [46] Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
    Duan, Yangyang
    Wang, Xueqi
    Li, Qiubo
    Sun, Shijiang
    Liang, Xi
    Li, Huijing
    Huang, Jing
    Zhao, Tianhe
    Hu, Jingnan
    Liu, Jianxin
    Hu, Zhenbiao
    He, Jianming
    MEDICINE, 2022, 101 (51) : E31850
  • [47] Predictive factors of response to cyclosporine (CsA) in severe steroid-refractory ulcerative colitis (SSRUC)
    Cacheux, Walfran
    Lemann, Marc
    Mancau, Philippe
    Seksik, Philippe
    Nion-Larmurier, Isabelle
    Afchain, Pauline
    Allez, Mathieu
    Fady, Daniel
    Beaugerie, Laurent
    Gendre, Jean-Pierre
    Cosnes, Jacques
    GASTROENTEROLOGY, 2006, 130 (04) : A143 - A143
  • [48] Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
    Cacheux, Wulfran
    Seksik, Philippe
    Lemann, Marc
    Marteau, Philippe
    Nion-Larmurier, Isabelle
    Afchain, Pauline
    Daniel, Fady
    Beaugerie, Laurent
    Cosnes, Jacques
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03): : 637 - 642
  • [49] Cost-effectiveness analysis of infliximab versus CinnoRA in the treatment of moderate to severe ulcerative colitis in Iranian patients
    Olfatifar, Meysam
    Aghdaei, Hamid Asadzadeh
    Dehkordi, Ayda Hasanpour
    Shahrokh, Shabnam
    Pourhoseingholi, Mohamad Amin
    Balaii, Hedieh
    Rajabnia, Mohsen
    Ivanchuk, Maria
    Ivanchuk, Pavlo
    Nazari, Saeed Hashemi
    Sabour, Siamak
    Rohani, Pejman
    Mehralian, Gholamhossein
    Khodakarim, Soheila
    Hatami, Behzad
    Malekpour, Habib
    Sherkat, Ghazal
    Zali, Mohammad Reza
    Pordanjani, Sajjad Rahimi
    IMMUNOPATHOLOGIA PERSA, 2023, 9 (02):
  • [50] Analysis of the Clinical Efficacy of Infliximab in the Treatment of Steroid-Refractory Ulcerative Colitis in Children
    Chen, Ying
    Xiao, Feiwen
    Wang, Yang
    Sun, Mei
    Teng, Xu
    IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (03)
12345